Cardiac transcriptome analysis in obesity-related hypertension

Hypertension

Volumn 41, Issue 3 I, 2003, Pages 414-421

  Philip Couderc, Pierre ^a   Smih, Fatima ^a   Pelat, Michel ^a   Vidal, Cyril ^a   Verwaerde, Patrick ^a   Pathak, Atul ^a   Buys, Sophie ^a   Galinier, Michel ^a   Senard, Jean Michel ^a   Rouet, Philippe ^a  

^a INSERM   (France)

Author keywords

Dogs; Heart; Heart rate; Hypertension, arterial; Obesity

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

AMINO ACID SEQUENCE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA LIBRARY; DNA MICROARRAY; DOG; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE IDENTIFICATION; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART RATE; HEART RIGHT ATRIUM; HYBRIDIZATION; HYPERTENSION; LIPID DIET; METABOLISM; NONHUMAN; NORTHERN BLOTTING; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RNA EXTRACTION; SEQUENCE ANALYSIS; WEIGHT GAIN;

EID: 0037338685     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000057573.32425.95     Document Type: Article

References (54)

1. Seidell JC, Flegal KM. Assessing obesity: classification and epidemiology. Br Med Bull. 1997;53:238-252.
2. Bray GA. Health hazards of obesity. Endocrinol Metab Clin North Am. 1996;25:907-919.
3. Kannel WB. Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens. 2000;14:83-90.
4. Hall JE, Brands MW, Hildebrandt DA, Mizelle HL. Obesity-associated hypertension: hyperinsulinemia and renal mechanisms. Hypertension. 1992;19(suppl I):I-45-I-55.
5. Laakso M, Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis. 1998; 137:S65-S73.
6. Pelkonen R, Nikkila EA, Koskinen S, Penttinen K, Sarna S. Association of serum lipids and obesity with cardiovascular mortality. BMJ. 1977;2: 1185-1187.
7. Ascaso JF, Sales J, Merchante A, Real J, Lorente R, Martinez-Valls J, Carmena R. Influence of obesity on plasma lipoproteins, glycaemia and insulinaemia in patients with familial combined hyperlipidaemia. Int J Obes Relat Metab Disord. 1997;21:360-366.
8. Nicholas SB. Lipid disorders in obesity. Curr Hypertens Rep. 1999;1: 131-136.
9. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Annu Rev Nutr. 2001;21:1-21.
10. Redon J. Hypertension in obesity. Nutr Metab Cardiovasc Dis. 2001;11: 344-353.
11. Verwaerde P, Senard JM, Galinier M, Rouge P, Massabuau P, Galitzky J, Berlan M, Lafontan M, Montastruc JL. Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs. J Hypertens. 1999;17:1135-1143.
12. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, Ota M, Nagai K, Araki T, Satoh H, Ito S, Hisamichi S, Imai Y. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000;36:901-906.
13. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, Czajkowski SM, O'Connor C, Stone PH, Freedland KE. Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001;104:2024-2028.
14. Alpert MA, Hashimi MW. Obesity and the heart. Am J Med Sci. 1993;306:117-123.
15. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313.
16. Rocchini AP, Moorehead C, Wentz E, Deremer S. Obesity-induced hypertension in the dog. Hypertension. 1987;9(suppl III):III-64-III-68.
17. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension. 1993; 22:292-299.
18. Massabuau P, Verwaerde P, Galinier M, Fourcade J, Rouge P, Galitzky J, Senard JM, Berlan M, Bounhoure JP, Montastruc JL. Left ventricular repercussion of obesity-induced arterial hypertension in the dog. Arch Mal Coeur Vaiss. 1997;90:1033-1035.
19. Pelat M, Verwaerde P, Merial C, Galitzky J, Berlan M, Montastruc JL, Senard JM. Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension. Hypertension. 1999;34:1066-1072.
20. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 1996;93:6025-6030.
21. Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM. Expression profiling using cDNA microarrays. Nat Genet. 1999;21:10-14.
22. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nature Genetics. 1999;21:33-37.
23. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-618.
24. Gelzer AR, Ball HA. Validation of a telemetry system for measurement of blood pressure, electrocardiogram and locomotor activity in beagle dogs. Clin Exp Hypertens. 1997;19:1135-1160.
25. Rebrikov DV, Britanova OV, Gurskaya NG, Lukyanov KA, Tarabykin VS, Lukyanov SA. Mirror orientation selection (MOS): a method for eliminating false positive clones from libraries generated by suppression subtractive hybridization. Nucleic Acids Res. 2000;28:E90.
26. Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, Roberts CJ, Stoughton R, Burchard J, Slade D, Dai H, Bassett DE Jr, Hartwell LH, Brown PO, Friend SH. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med. 1998;4: 1293-1301.
27. Sehl PD, Tai JT, Hillan KJ, Brown LA, Goddard A, Yang R, Jin H, Lowe DG. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation. 2000;101:1990-1999.
28. Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem. 2000;275:6580-6585.
29. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF Jr, Hampton GM. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 2001;61:5974-5978.
30. Yu Z, Ford BN, Glickman BW. Identification of genes responsive to BPDE treatment in HeLa cells using cDNA expression assays. Environ Mol Mutagen. 2000;36:201-205.
31. Brands MW, Hall JE, Van Vliet BN, Alonso-Galicia M, Herrera GA, Zappe D. Obesity and hypertension: roles of hyperinsulinemia, sympathetic nervous system and intrarenal mechanisms. J Nutr. 1995;125: 1725S-1731S.
32. Yang GP, Ross DT, Kuang WW, Brown PO, Weigel RJ. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res. 1999;27:1517-1523.
33. Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, Hawthorn L, Mitchell CA, Young JB, Francis GS, McCarthy PM, Bond M. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation. 2000;102:3046-3052.
34. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res. 2001;89:201-210.
35. Hwang DM, Dempsey AA, Lee CY, Liew CC. Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics. 2000;66:1-14.
36. Seccia TM, Atlante A, Vulpis V, Marra E, Passarella S, Pirrelli A. Mitochondrial energy metabolism in the left ventricular tissue of spontaneously hypertensive rats: abnormalities in both adeninenucleotide and phosphate translocators and enzyme adenylate-kinase and creatine-phosphokinase activities. Clin Exp Hypertens (New York). 1998;20: 345-358.
37. Atlante A, Seccia TM, Pierro P, Vulpis V, Marra E, Pirrelli A, Passarella S. ATP synthesis and export in heart left ventricle mitochondria from spontaneously hypertensive rat. Int J Mol Med. 1998;1:709-716.
38. Opie LH. The Heart, Physiology From Cell to Regulation. 3rd ed. Baltimore, Md: Lippincott Williams & Wilkins; 1998:377-378.
39. Roti E, Minelli R, Salvi M. Thyroid hormone metabolism in obesity. Int J Obes Rel Metab Disord. 2000;24(suppl 2):S113-S115.
40. Nagai R, Zarain-Herzberg A, Brandl CJ, Fujii J, Tada M, MacLennan DH, Alpert NR, Periasamy M. Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci U A. 1989;86:2966-2970.
41. Tabak LA. In defense of the oral cavity: structure, biosynthesis, and function of salivary mucins. Annu Rev Physiol. 1995;57:547-564.
42. Sawada T, Ho JJ, Chung YS, Sowa M, Kim YS. E-selectin binding by pancreatic tumor cells is inhibited by cancer sera. Int J Cancer. 1994;57:901-907.
43. Hayrick JS. A family of heptahelical receptors with adhesion-like domains: a marriage between two super families. J Recept Signal Transduct Res. 2000;20:119-131.
44. Mercadier JJ, Lompre AM, Duc P, Boheler KR, Fraysse JB, Wisnewsky C, Allen PD, Komajda M, Schwartz K. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 1990;85:305-309.
45. Anversa P, Capasso JM, Olivetti G, Sonnenblick EH. Cellular basis of ventricular remodeling in hypertensive cardiomyopathy. Am J Hypertens. 1992;5:758-770.
46. Yung BY, Bor AM, Yang YH. Immunolocalization of phosphoprotein B23 in proliferating and non-proliferating HeLa cells. Int J Cancer. 1990;46:272-275.
47. Skaar TC, Prasad SC, Sharareh S, Lippman ME, Brunner N, Clarke R. Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen- independence in human breast cancer cells. J Steroid Biochem Mol Biol. 1998;67:391-402.
48. Dingwall C, Laskey RA. Nucleoplasmin: the archetypal molecular chaperone. Semin Cell Biol. 1990;1:11-17.
49. Szebeni A, Olson MO. Nucleolar protein B23 has molecular chaperone activities. Protein Sci. 1999;8:905-912.
50. Laskey RA, Mills AD, Philpott A, Leno GH, Dilworth SM, Dingwall C. The role of nucleoplasmin in chromatin assembly and disassembly. Philos Trans R Soc Lond B Biol Sci. 1993;339:263-269.
51. Cheng M, Zhen E, Robinson MJ, Ebert D, Goldsmith E, Cobb MH. Characterization of a protein kinase that phosphorylates serine 189 of the mitogen-activated protein kinase homolog ERK3. J Biol Chem. 1996;271:12057-12062.
52. Sauma S, Friedman E. Increased expression of protein kinase C beta activates ERK3. J Biol Chem. 1996;271:11422-11426.
53. Janulis M, Trakul N, Greene G, Schaefer EM, Lee JD, Rosner MR. A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity. Mol Cell Biol. 2001;21:2235-2247.
54. Zimmermann J, Lamerant N, Grossenbacher R, Furst P. Proteasome- and p38-dependent regulation of ERK3 expression. J Biol Chem. 2001;276:10759-10766.